Carregant...

Comparative Bioavailability and Tolerability of a Single 2-mg Dose of 2 Repaglinide Tablet Formulations in Fasting, Healthy Chinese Male Volunteers: An Open-Label, Randomized-Sequence, 2-Period Crossover Study()

BACKGROUND: Repaglinide, an oral insulin secretagogue, was the first meglitinide analogue to be approved for use in patients with type 2 diabetes mellitus. OBJECTIVE: In our study, the bioavailability and tolerability of the proposed generic formulation with the established reference formulation of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhai, Xue-jia, Hu, Kai, Chen, Fen, Lu, Yong-ning
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3898188/
https://ncbi.nlm.nih.gov/pubmed/24465043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2013.08.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!